UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
March 18, 2022
Akumin Inc.
(Exact name of Registrant as specified in its charter)
Ontario | 001-39479 | |||
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
8300 W. Sunrise Boulevard Plantation, Florida |
33322 | |
(Address of principal executive offices) | (Zip Code) |
(844) 730-0050
(Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered or to be registered pursuant to Section 12(b) of the Act.
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
Common Shares, no par value | AKU | The Nasdaq Stock Market LLC | ||
Common Shares, no par value | AKU | Toronto Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers. |
On March 18, 2022, Akumin Inc. announced the termination of employment of its President and Co-Chief Executive Officer, Rhonda Longmore-Grund, effective March 18, 2022, following the decision by its board of directors to not continue with the co-CEO arrangement. In accordance with her severance agreement, Ms. Longmore-Grund is entitled to receive continued salary, bonus and insurance subsidy for the 18 month period following the termination date as well reimbursement for costs of outplacement services. Riadh Zine will remain as Chairman and Chief Executive Officer of Akumin. See the press release attached as Exhibit 99.1.
Item 9.01. | Financial Statements and Exhibits. |
(d) Exhibits
Exhibit No. |
Description | |
99.1 | Press release dated March 18, 2022 | |
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Akumin Inc. | ||||||
Date: March 21, 2022 | By: | /s/ Matt Cameron | ||||
Matt Cameron Chief Legal Officer and Corporate Secretary |
Exhibit 99.1
Akumin Announces Executive Departure
March 18, 2022 Plantation, FL Akumin Inc. (NASDAQ/TSX: AKU) (Akumin or the Company) announced the departure of its President and Co-Chief Executive Officer, Rhonda Longmore-Grund, effective today, following the decision by its board of directors to not continue with the co-CEO arrangement. Riadh Zine will remain as Chairman and Chief Executive Officer of Akumin.
Ms. Longmore-Grund became President and Co-Chief Executive Officer of Akumin on the closing of the acquisition by the Company of Alliance HealthCare Services, Inc. (Alliance) on September 1, 2021. She has since assisted the Company with the integration of the two businesses.
Riadh Zine, Chairman and Chief Executive Officer of Akumin, commented, On behalf of the board of directors of Akumin, I would like to thank Rhonda for her dedication and contributions to date. Rhonda successfully assisted us through a period of transition following our acquisition of Alliance, which has secured Akumins position as one of the most comprehensive radiology and oncology solutions providers in the United States. We wish her the very best in her next endeavors.
About Akumin
Akumin is a national partner of choice for U.S. hospitals, health systems and physician groups, with comprehensive solutions addressing outsourced radiology and oncology service line needs. Akumin provides: (1) fixed-site outpatient diagnostic imaging services through a network of more than 200 owned and/or operated imaging locations; and (2) outpatient radiology and oncology services and solutions to approximately 1,000 hospitals and health systems across 46 states. By combining clinical and operational expertise with the latest advances in technology and information systems, Akumin facilitates more efficient and effective diagnosis and treatment for patients and their providers. Akumins imaging procedures include MRI, CT, positron emission tomography (PET and PET/CT), ultrasound, diagnostic radiology (X-ray), mammography, and other interventional procedures; cancer care services include a full suite of radiation therapy and related offerings. For more information, visit www.akumin.com and www.alliancehealthcareservices-us.com.
For further information:
R. Jeffrey White
Investor Relations
1-866-640-5222
jeffrey.white@akumin.com